|
1
|
Saffran M and Schally AV: Effect of
histamine, hog vasopressin, and corticotropin-releasing factor
(CRF) on ACTH release in vitro. Proc Soc Exp Biol Med. 92:636–637.
1956. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schally AV, Saffran M and Zimmermann B: A
Corticotrophin-releasing factor: Partial purification and amino
acid composition. Biochem J. 70:97–103. 1958. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fekete EM and Zorrilla EP: Physiology,
pharmacology, and therapeutic relevance of urocortins in mammals:
Ancient CRF paralogs. Front Neuroendocrinol. 28:1–27. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jhang JF, Birder LA, Jiang YH, Hsu YH, Ho
HC and Kuo HC: Dysregulation of bladder corticotropin-releasing
hormone receptor in the pathogenesis of human interstitial
cystitis/bladder pain syndrome. Sci Rep. 9:191692019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coste SC, Kesterson RA, Heldwein KA,
Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA,
Hohimer AR, et al: Abnormal adaptations to stress and impaired
cardiovascular function in mice lacking corticotropin-releasing
hormone receptor-2. Nat Genet. 24:403–409. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Corder R, Turnill D, Ling N and Gaillard
RC: Attenuation of corticotropin releasing factor-induced
hypotension in anesthetized rats with the CRF antagonist,
alpha-helical CRF9-41; comparison with effect on ACTH release.
Peptides. 13:1–6. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ellmers LJ, Scott NJ, Cameron VA, Richards
AM and Rademaker MT: Chronic urocortin 2 administration improves
cardiac function and ameliorates cardiac remodeling after
experimental myocardial infarction. J Cardiovasc Pharmacol.
65:269–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bale TL, Hoshijima M, Gu Y, Dalton N,
Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL, et
al: The cardiovascular physiologic actions of urocortin II: Acute
effects in murine heart failure. Proc Natl Acad Sci USA.
101:3697–3702. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinez V, Wang L, Million M, Rivier J
and Taché Y: Urocortins and the regulation of gastrointestinal
motor function and visceral pain. Peptides. 25:1733–1744. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lenz HJ: Regulation of duodenal
bicarbonate secretion during stress by corticotropin-releasing
factor and beta-endorphin. Proc Natl Acad Sci USA. 86:1417–1420.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Larauche M, Kiank C and Tache Y:
Corticotropin releasing factor signaling in colon and ileum:
Regulation by stress and pathophysiological implications. J Physiol
Pharmacol. 60 (Suppl 7):S33–S46. 2009.
|
|
12
|
Moss AC, Anton P, Savidge T, Newman P,
Cheifetz AS, Gay J, Paraschos S, Winter MW, Moyer MP, Karalis K, et
al: Urocortin II mediates Pro-inflammatory effects in human
colonocytes via corticotropin-releasing hormone receptor 2alpha.
Gut. 56:1210–1217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Enkhmaa D, Wall D, Mehta PK, Stuart JJ,
Rich-Edwards JW, Merz CN and Shufelt C: Preeclampsia and vascular
function: A window to future cardiovascular disease risk. J Womens
Health (Larchmt). 25:284–291. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herrera CL, Bowman ME, McIntire DD, Nelson
DB and Smith R: Revisiting the placental clock: Early
Corticotrophin-releasing hormone rise in recurrent preterm birth.
PLoS One. 16:e02574222021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jones SA and Challis JRG: Local
stimulation of prostagiandin production by Corttcotropin-releasing
hormone in human fetal membranes and placenta. Biochem Biophys Res
Commun. 159:192–199. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vannuccini S, Bocchi C, Severi FM, Challis
JR and Petraglia F: Endocrinology of human parturition. Ann
Endocrinol (Paris). 77:105–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dautzenberg FM and Hauger RL: The CRF
peptide family and their receptors: Yet more partners discovered.
Trends Pharmacol Sci. 23:71–77. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hauger RL, Grigoriadis DE, Dallman MF,
Plotsky PM, Vale WW and Dautzenberg FM: International Union of
Pharmacology. XXXVI. Current status of the nomenclature for
receptors for corticotropin-releasing factor and their ligands.
Pharmacol Rev. 55:21–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Audhya T, Jain R and Hollander CS:
Receptor-mediated immunomodulation by corticotropin-releasing
factor. Cellular Immunology. 134:77–84. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dermitzaki E, Venihaki M, Tsatsanis C,
Gravanis A, Avgoustinaki PD, Liapakis G and Margioris AN: The
multi-faceted profile of corticotropin-releasing factor (CRF)
family of neuropeptides and of their receptors on the
paracrine/local regulation of the inflammatory response. Curr Mol
Pharmacol. 11:39–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Y, Hu J, Zhang R, Zhou C, Xu Y, Guan X
and Li S: Enhanced intracellular calcium induced by urocortin is
involved in degranulation of rat lung mast cells. Cell Physiol
Biochem. 21:173–182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mavridis C, Venihaki M, Dermitzaki E,
Deiktakis M, Liapakis G and Mamoulakis C: mRNA expression of CRF
family members in urothelial bladder cancer. Oncol Lett. 27:132024.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bardin CW, Shaha C, Mather J, Salomon Y,
Margioris AN, Liotta AS, Gerendai I, Chen CL and Krieger DT:
Identification and possible function of
pro-opiomelanocortin-derived peptides in the testis. Ann N Y Acad
Sci. 438:346–364. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thompson RC, Seasholtz AF and Herbert E:
Rat corticotropin-releasing hormone gene: Sequence and
tissue-specific expression. Mol Endocrinol. 1:363–370. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoon DJ, Sklar C and David R: Presence of
immunoreactive corticotropin-releasing factor in rat testis.
Endocrinology. 122:759–761. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Audhya T, Hollander CS, Schlesinger DH and
Hutchinson B: Structural characterization and localization of
corticotropin-releasing factor in testis. Biochim Biophys Acta.
995:10–16. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ulisse S, Fabbri A and Dufau ML:
Corticotropin-releasing factor receptors and actions in rat Leydig
cells. J Biol Chem. 264:2156–2163. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fabbri A, Tinajero JC and Dufau ML:
Corticotropin-releasing factor is produced by rat Leydig cells and
has a major local antireproductive role in the testis.
Endocrinology. 127:1541–1543. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dufau ML, Tinajero JC and Fabbri A:
Corticotropin-releasing factor: An antireproductive hormone of the
testis. FASEB J. 7:299–307. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang BM, Stocco DM, Hutson JC and Norman
RL: Corticotropin-releasing hormone stimulates steroidogenesis in
mouse Leydig cells. Biol Reprod. 53:620–626. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heinrich N, Meyer MR, Furkert J, Sasse A,
Beyermann M, Bönigk W and Berger H: Corticotropin-releasing factor
(CRF) agonists stimulate testosterone production in mouse leydig
cells through CRF receptor-1. Endocrinology. 139:651–658. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tao J, Lin M, Sha J, Tan G, Soong TW and
Li S: Separate locations of urocortin and its receptors in mouse
testis: Function in male reproduction and the relevant mechanisms.
Cell Physiol Biochem. 19:303–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rivier CL: Urocortin 1 inhibits rat leydig
cell function. Endocrinology. 149:6425–6432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee S, Braden B, Kang SS and Rivier C:
Urocortins are present in the rat testis. Neuropeptides.
45:131–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McDowell EN, Kisielewski AE, Pike JW,
Franco HL, Yao HH and Johnson KJ: A transcriptome-wide screen for
mRNAs enriched in fetal Leydig cells: CRHR1 agonism stimulates rat
and mouse fetal testis steroidogenesis. PLoS One. 7:e473592012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Asa SL, Kovacs K, Vale W, Petrusz P and
Vecsei P: Immunohistologic localization of corticotrophin-releasing
hormone in human tumors. Am J Clin Pathol. 87:327–333. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Arcuri F, Cintorino M, Florio P, Floccari
F, Pergola L, Romagnoli R, Petraglia F, Tosi P and Teresa Del
Vecchio M: Expression of urocortin mRNA and peptide in the human
prostate and in prostatic adenocarcinoma. Prostate. 52:167–172.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tezval H, Merseburger AS, Seidler M, Serth
J, Kuczyk MA and Oelke M: Expression of corticotropin releasing
factor receptor 2 (CRFR2) in the human prostate. A new potential
target for medical therapy of benign prostatic hyperplasia. Urologe
A. 47:1082–1084. 2008.(In German).
|
|
39
|
Tezval H, Jurk S, Atschekzei F, Serth J,
Kuczyk MA and Merseburger AS: The involvement of altered
corticotropin releasing factor receptor 2 expression in prostate
cancer due to alteration of Anti-angiogenic signaling pathways.
Prostate. 69:443–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin L, Zhang Q, Guo R, Wang L, Wang J, Wan
R, Zhang R, Xu Y and Li S: Different effects of
corticotropin-releasing factor and urocortin 2 on apoptosis of
prostate cancer cells in vitro. J Mol Endocrinol. 47:219–227. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Birder LA: More than just a barrier:
Urothelium as a drug target for urinary bladder pain. Am J Physiol
Renal Physiol. 289:F489–F495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Birder LA, Kanai AJ, de Groat WC, Kiss S,
Nealen ML, Burke NE, Dineley KE, Watkins S, Reynolds IJ and
Caterina MJ: Vanilloid receptor expression suggests a sensory role
for urinary bladder epithelial cells. Proc Natl Acad Sci USA.
98:13396–13401. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Murray E, Malley SE, Qiao LY, Hu VY and
Vizzard MA: Cyclophosphamide induced cystitis alters neurotrophin
and receptor tyrosine kinase expression in pelvic ganglia and
bladder. J Urol. 172:2434–2439. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vincent SR and Satoh K:
Corticotropin-releasing factor (CRF) immunoreactivity in the
dorsolateral pontine tegmentum: Further studies on the micturition
reflex system. Brain Res. 308:387–391. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Valentino RJ, Page ME, Luppi PH, Zhu Y,
Van Bockstaele E and Aston-Jones G: Evidence for widespread
afferents to Barrington's nucleus, a brainstem region rich in
corticotropin-releasing hormone neurons. Neuroscience. 62:125–143.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pavcovich LA and Valentino RJ: Central
regulation of micturition in the rat the corticotropin-releasing
hormone from Barrington's nucleus. Neurosci Lett. 196:185–188.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Klausner AP, Streng T, Na YG, Raju J,
Batts TW, Tuttle JB, Andersson KE and Steers WD: The role of
corticotropin releasing factor and its antagonist, astressin, on
micturition in the rat. Auton Neurosci. 123:26–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
McFadden K, Griffin TA, Levy V, Wolfe JH
and Valentino RJ: Overexpression of corticotropin-releasing factor
in Barrington's nucleus neurons by adeno-associated viral
transduction: Effects on bladder function and behavior. Eur J
Neurosci. 36:3356–3364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Seki M, Zha XM, Inamura S, Taga M, Matsuta
Y, Aoki Y, Ito H and Yokoyama O: Role of Corticotropin-releasing
factor on bladder function in rats with psychological stress. Sci
Rep. 9:98282019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Van Batavia JP, Butler S, Lewis E, Fesi J,
Canning DA, Vicini S, Valentino RJ and Zderic SA:
Corticotropin-releasing hormone from the pontine micturition center
plays an inhibitory role in micturition. J Neurosci. 41:7314–7325.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Robbins MT, DeWitte C and Ness TJ:
Stress-induced bladder hypersensitivity: Effect of corticotropin
releasing factor receptors assessed by spinal neurophysiology and
neurochemistry. Neuropharmacology. 224:1093692023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Klausner AP and Steers WD: Corticotropin
releasing factor: A mediator of emotional influences on bladder
function. J Urol. 172:2570–2573. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rothrock NE, Lutgendorf SK, Kreder KJ,
Ratliff T and Zimmerman B: Stress and symptoms in patients with
interstitial cystitis: A life stress model. Urology. 57:422–427.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Saban MR, Nguyen NB, Hammond TG and Saban
R: Gene expression profiling of mouse bladder inflammatory
responses to LPS, substance P, and Antigen-stimulation. Am J
Pathol. 160:2095–2110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
LaBerge J, Malley SE, Zvarova K and
Vizzard MA: Expression of corticotropin-releasing factor and CRF
receptors in micturition pathways after cyclophosphamide-induced
cystitis. Am J Physiol Regul Integr Comp Physiol. 291:R692–R703.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Boucher W, Kempuraj D, Michaelian M and
Theoharides TC: Corticotropin-releasing hormone-receptor 2 is
required for acute stress-induced bladder vascular permeability and
release of vascular endothelial growth factor. BJU Int.
106:1394–1399. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hanna-Mitchell AT, Wolf-Johnston A,
Roppolo JR, Buffington TC and Birder LA: Corticotropin-releasing
factor family peptide signaling in feline bladder urothelial cells.
J Endocrinol. 222:113–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kageyama K, Bradbury MJ, Zhao L, Blount AL
and Vale WW: Urocortin messenger ribonucleic acid: Tissue
distribution in the rat and regulation in thymus by
lipopolysaccharide and glucocorticoids. Endocrinology.
140:5651–5658. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen A, Blount A, Vaughan J, Brar B and
Vale W: Urocortin II gene is highly expressed in mouse skin and
skeletal muscle tissues: Localization, basal expression in
corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null
mice, and regulation by glucocorticoids. Endocrinology.
145:2445–2457. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yamauchi N, Otagiri A, Nemoto T, Sekino A,
Oono H, Kato I, Yanaihara C and Shibasaki T: Distribution of
urocortin 2 in various tissues of the rat. J Neuroendocrinol.
17:656–663. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Takahashi K, Totsune K, Murakami O, Saruta
M, Nakabayashi M, Suzuki T, Sasano H and Shibahara S: Expression of
urocortin III/stresscopin in human heart and kidney. J Clin
Endocrinol Metab. 89:1897–1903. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tezval H, Jurk S, Atschekzei F, Becker JU,
Jahn O, Serth J and Kuczyk MA: Urocortin and
corticotropin-releasing factor receptor 2 in human renal cell
carcinoma: Disruption of an endogenous inhibitor of angiogenesis
and proliferation. World J Urol. 27:825–830. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tezval H, Atschekzei F, Peters I, Waalkes
S, Hennenlotter J, Stenzl A, Becker JU, Merseburger AS, Kuczyk MA
and Serth J: Reduced mRNA expression level of
corticotropin-releasing Hormone-binding protein is associated with
aggressive human kidney cancer. BMC Cancer. 13:1992013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Faraj Tabrizi P, Mohebbi Tafrechi A,
Peters I, Atschekzei F, Kuczyk MA, Serth J and Tezval H:
Cancer-specific loss of urocortin 3 in human renal cancer. Adv
Ther. 37:288–299. 2020. View Article : Google Scholar : PubMed/NCBI
|
